Rephonic
Artwork for The Readout Loud

The Readout Loud

STAT
FDA
Vertex Pharmaceuticals
Venture Capital
CRISPR
Gilead Sciences
Rick Gonzalez
Obesity Treatments
Opioid Addiction
Biotechnology
Sanofi
Clinical Trials
Abbvie
Pfizer
Aduhelm
Drug Development
Biotech Financing
Eli Lilly
Oncology
Car-T
Casgevi

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

PublishesWeeklyEpisodes397Founded8 years ago
Number of ListenersCategory
Business

Listen to this Podcast

Artwork for The Readout Loud

Latest Episodes

How was a known friend of Jeffrey Epstein able to raise $100 million, with the help of a prominent biotech VC? And will Vinay Prasad return to the Food and Drug Administration for a "three-peat"?

Damian Garde joins Allison, Adam, and Elaine to discu... more

Will drugmakers finally be able to breach the efficacy ceiling in inflammatory bowel disease? And is the Food and Drug Administration being flexible enough with rare disease treatments?

Spyre Therapeutics CEO Cameron Turtle joins the podcast to disc... more

On "The Readout LOUD" this week: Adam Feuerstein, solo. His usual co-hosts Allison DeAngelis and Elaine Chen took some time off, so Adam manned the podcast mic himself.

Adam thought, quite understandably, that our cherished listeners wouldn’t want t... more

Was Hims' Super Bowl ad the final straw for regulators? Is the bar being lowered for psychedelic medicines? And what's happening behind-the-scenes with Moderna and the Food and Drug Administration?

We discuss all that on this week's episode of "The ... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

Recent Guests

Cameron Turtle
CEO of Spyre Therapeutics
Spyre Therapeutics
Episode: 391: Breaching the IBD efficacy ceiling, and sham surgeries
Katie Palmer
Colleague discussing Hims' recent controversies
STAT
Episode: 389: Hims' Super Bowl fallout, and the FDA reverses course
Vinay Prasad
Director of the Center for Biologics Evaluation and Research at the FDA
FDA
Episode: 388: The FDA's refusal to review Moderna's mRNA flu vaccine
Jesse Goodman
Former head of CBER from 2003 to 2009
FDA
Episode: 388: The FDA's refusal to review Moderna's mRNA flu vaccine
Joe Bagnoli
A successful lawyer from St. Paul, Minnesota, and long-time Lipitor user
Practicing Lawyer in the Twin Cities
Episode: From Drug Story: Lipitor and Heart Disease
Dr. Rita Redberg
Professor of Medicine and Cardiologist at University of California, San Francisco
University of California, San Francisco
Episode: From Drug Story: Lipitor and Heart Disease
Lauren Holder
Patient advocate and producer/host of the Help for HD podcast
Help for HD International
Episode: 386: The high stakes for Huntington's patients
Mike Doustdar
CEO of Novo Nordisk
Novo Nordisk
Episode: 384: Live from the JP Morgan conference, a sit-down with Novo Nordisk's CEO and VC Bob Nelsen
Bob Nelsen
Co-founder and managing director of ARCH Venture Partners
ARCH Venture Partners
Episode: 384: Live from the JP Morgan conference, a sit-down with Novo Nordisk's CEO and VC Bob Nelsen

Hosts

Adam Feuerstein
Host of The Readout Loud.
Allison DeAngelis
Host of The Readout Loud.
Elaine Chen
Host of The Readout Loud.

Reviews

4.7 out of 5 stars from 582 ratings
  • David Olson

    Thoughtful and concise discussion about drug development processes. I found this illuminating

    and hopeful

    Apple Podcasts
    5
    Auldkirk
    United Kingdom3 months ago
  • Really informative and relevant

    Great coverage by the three hosts.

    Only area of improvement is if the audio editor can adjust the volume for all speakers to be equal because for some reason Elaine’s mic tends to be the loudest and I have to keep adjusting the volume for each speaker.

    Apple Podcasts
    4
    orange03$592
    United States4 months ago
  • Great pod!

    This is a great overview of the biopharm space with an engaging and fun style. I also like the unrelated chat amongst the team, particularly as a fellow fan of the Great British Bake Off, given this is an industry that can often take itself very seriously!

    Apple Podcasts
    5
    123etcetc
    United Kingdom5 months ago
  • Please reboot the old quality bar

    This podcast was a gold mine a few years back. Really miss that run you had. Adam is good but even he was better back when surrounded with higher caliber cohosts.

    Apple Podcasts
    3
    freedomtochoose
    United States6 months ago
  • Way Too Political

    Like others have mentioned, this podcast has become way too political in how it covers this sector. Please cover the content with a little bit more neutrality, because it erodes the credibility of the hosts.

    Apple Podcasts
    2
    Kitten Kitten Star
    United States7 months ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Thoughtful and concise discussion about drug development processes.
Quality content but some listeners feel hosts could improve articulation skills.
Engaging and fun style; informative coverage of the biopharm space.
Critique of political undertones in discussions.
Broadly relevant for biotechnology news and updates.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#206
Belgium/Business

Talking Points

Recent interactions between the hosts and their guests.

389: Hims' Super Bowl fallout, and the FDA reverses course
Q: Why do you think regulators are acting now in particular against Hims?
Regulators may have felt provoked by Hims' aggressive marketing, especially after their Super Bowl ad, and have acted due to a combination of visibility and timing in the market.
389: Hims' Super Bowl fallout, and the FDA reverses course
Q: What impact is this situation likely to have on Hims' business model?
The legal controversies and regulatory scrutiny have already affected Hims' stock and business model significantly, leading to changes in how they operate in the telehealth market.
389: Hims' Super Bowl fallout, and the FDA reverses course
Q: Can you give us a quick recap of what has happened in the past few weeks with Hims and this controversial decision to launch this pill product?
Hims launched a compounded version of Novo's GLP-1 drug, which led to lawsuits and a significant regulatory crackdown, including an FDA statement and a lawsuit from Novo.
388: The FDA's refusal to review Moderna's mRNA flu vaccine
Q: How do you reply to that?
We were investing almost a billion dollars in that phase three and this dramatic refusal feels unwarranted after prior agreement from the FDA.
388: The FDA's refusal to review Moderna's mRNA flu vaccine
Q: So one of the big ideas for mRNA vaccines has always been to develop flu shots using that technology?
Moderna's clinical trial was not adequate and well-controlled, according to the FDA.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About The Readout Loud

What is The Readout Loud about and what kind of topics does it cover?

This weekly podcast provides insightful analyses and discussions on the latest developments in the biotechnology industry, covering significant news, regulatory challenges, and the interplay between pharmaceutical companies and the government. Each episode features hosts breaking down complex topics such as drug pricing, the implications of FDA decisions, and new treatments in the biotech sphere, making it accessible for both industry insiders and curious listeners alike. Besides focusing on major companies like Novo Nordisk and Eli Lilly, the dialogue often touches on broader societal themes, including patient advocacy and public health, engaging a diverse audience interested in medicine's future.

Unique for its expert guests and engaging... more

Where can I find podcast stats for The Readout Loud?

Rephonic provides a wide range of podcast stats for The Readout Loud. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The Readout Loud and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does The Readout Loud get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for The Readout Loud, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for The Readout Loud?

Rephonic provides comprehensive predictive audience data for The Readout Loud, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does The Readout Loud have?

To see how many followers or subscribers The Readout Loud has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to The Readout Loud?

These podcasts share a similar audience with The Readout Loud:

1. BioCentury This Week
2. Biotech Hangout
3. The Long Run with Luke Timmerman
4. Business Of Biotech
5. The BioCentury Show

How many episodes of The Readout Loud are there?

The Readout Loud launched 8 years ago and published 397 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact The Readout Loud?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for The Readout Loud?

Rephonic pulls ratings and reviews for The Readout Loud from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for The Readout Loud?

Rephonic provides full transcripts for episodes of The Readout Loud. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on The Readout Loud?

Recent guests on The Readout Loud include:

1. Cameron Turtle
2. Katie Palmer
3. Vinay Prasad
4. Jesse Goodman
5. Joe Bagnoli
6. Dr. Rita Redberg
7. Lauren Holder
8. Mike Doustdar

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days